Market
Halozyme Therapeutics Inc [HALO] Is Currently -24.56 below its 200 Period Moving Avg: What Does This Mean?
Halozyme Therapeutics Inc [NASDAQ: HALO] loss -24.56% or -16.35 points to close at $50.23 with a heavy trading volume of 13995594 shares. The daily chart for HALO points out that the company has recorded -15.79% loss over the past six months. If we look at